“The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. The U.S. holds a larger share in the North American sleep apnea devices market with about 92.2% in 2013, followed by Canada. The North American sleep apnea devices market holds high potential for growth in future, due to a number of forces that favor this market.
These include the incessantly growing base of sleep apnea patients, increasing awareness with regards to sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancements. About 4% of men and 2% of women suffer from OSA, globally. Due to incessantly rising obesity rates and the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, stroke, etc., the global sleep apnea patient pool is likely to grow in the years to come. However, a dearth of reimbursement/insurance coverage and patient compliance seem to hinder the growth of this market.
In this report, the North American Sleep Apnea Devices market is broadly classified on the basis of segments that include sleep apnea therapeutic devices and sleep apnea diagnostic devices. Furthermore, on the basis of products, the sleep apnea diagnostic devices market is divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/In-Lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, on the basis of products, the sleep apnea therapeutic devices market is segmented into positive airway pressure (pap) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances.
Geographically, the market is divided into two countries, namely the U.S. and Canada. The U.S. is estimated to command the largest share of 92.2% in 2013, followed by Canada. Canada is estimated to grow at a CAGR of 16.8% during the forecast period from 2014 to 2019. As per the Centers for Disease Control and Prevention (CDC), 36.0% of the U.S. adults were obese in 2010 and nearly 42% will be obese by 2030. This dramatic increase in the obesity epidemic is likely to add to the pool of sleep apnea patients. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade. Over prescription of overnight tests to diagnose apnea has also contributed significantly to the escalating growth of the U.S. sleep apnea diagnostic devices market.
The report has profiled the leading players of this market along with their developments (new product launches & partnerships, agreements, collaborations, and joint ventures) over the past few years and strategies adopted by them to sustain and strengthen their position in the North American sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (The Netherlands); ResMed (U.S.); Compumedics Limited (Australia); CarefusionCorporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.), Itamar Medical, Ltd. (U.S.), and Weinmann Medical Devices GmbH & Co. KG (Germany), are some of the key players that are engaged in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North American sleep apnea devices market, high-growth regions & countries & their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both the established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share.
The report provides insights on the following pointers:
• Product Analysis and development: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the North American sleep apnea devices market. Usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data, along with a comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls.
• Market Development: Comprehensive information of the lucrative emerging markets. The report analyzes the market across geographies, exploit new distribution channels, new clientele base, and different pricing policies.
• Market Diversification: Exhaustive information of new products, untapped geographies, recent developments, and investments decisions in the sleep apnea devices market. Detailed description regarding related and unrelated diversification pertaining to this market.
• Epidemiology Data: The incidences and patient pool of obstructive sleep apnea (OSA).
• Competitive Assessment: In-depth assessment of market shares and company share analysis of the key players forecasted till 2019. Development business strategies and manufacturing capabilities of leading players that enhance the bottom line of the companies in the sleep apnea devices market.
• Product/Brand Perception Analysis: Comprehensive study of customers’ perception and behavior through our inbuilt social connect tool (digital marketing language) that checks the virality and tonality of blogs.
”
“TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET SEGMENTATION & COVERAGE 14
1.3 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET 16
2.2 ARRIVING AT THE SLEEP APNEA DEVICES MARKET SIZE 17
2.2.1 TOP-DOWN APPROACH 17
2.2.2 DEMAND SIDE APPROACH 17
2.2.2.1 INTRODUCTION 18
2.2.2.2 EPIDEMIOLOGY DATA 19
2.2.2.2.1 COPD 19
2.2.2.2.2 LUNG CANCER: 20
2.3 ASSUMPTIONS 20
3 EXECUTIVE SUMMARY 21
4 MARKET OVERVIEW 23
4.1 INTRODUCTION 23
4.1.1 STAGES OF SLEEP 23
4.1.1.1 SLEEP CYCLE 24
4.1.2 SLEEP DISORDERS 24
4.1.3 SLEEP APNEA 25
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE 25
4.1.5 CAUSES 26
4.1.5.1 CENTRAL SLEEP APNEA (CSA) 26
4.1.5.2 OBSTRUCTIVE SLEEP APNEA (OSA) 26
4.1.6 SIGNS & SYMPTOMS 26
4.1.6.1 CENTRAL SLEEP APNEA 26
4.1.6.2 OBSTRUCTIVE SLEEP APNEA(OSA) 27
4.1.6.3 SIGNS & SYMPTOMS IN CHILDREN 27
4.1.7 RISK FACTORS 27
4.1.7.1 CENTRAL SLEEP APNEA 27
4.1.7.2 OBSTRUCTIVE SLEEP APNEA (OSA) 28
4.1.8 DIAGNOSIS 28
4.1.8.1 SLEEP APNEA DIAGNOSIS & SLEEP RECORDING TEST 29
4.1.9 TREATMENT OPTIONS 29
4.1.10 CO-MORBID CONDITIONS 31
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET 31
4.3 MARKET DRIVERS AND INHIBITORS 32
4.4 KEY MARKET DYNAMICS 34
5 SLEEP APNEA DEVICES MARKET, BY SEGMENT 36
5.1 INTRODUCTION 37
5.2 NORTH AMERICA sleep apnea devices MARKET, TYPE COMPARISON WITH Respiratory and anesthesia devices MARKET 40
5.3 NORTH AMERICA sleep apnea diagnostic devices MARKET, BY product/GEOGRAPHY 40
5.3.1 North America Traditional Diagnostics Market, By Geography 42
5.3.2 North America Home Sleep Testing Devices Market, By Geography 44
5.3.3 North America Masks Market, By Type/Geography 49
5.3.3.1 North America Nasal Masks Market, By Geography 51
5.3.3.2 North America Full Face Masks Market, By Geography 51
5.3.3.3 North America Nasal Pillow Masks Market, By Geography 52
5.3.3.4 North America Oral Masks Market, By Geography 53
5.3.4 North America Respiratory Polygraphs Market, By Geography 54
5.3.5 North America Two Channel Screening Devices Market, By Geography 55
5.3.6 North America Single Channel Screening Devices (Pulse Oximeters) Market, By Type/Geography 56
5.3.6.1 North America Hand-Held Pulse Oximeters, By Geography 59
5.3.6.2 North America Wrist-Worn Pulse Oximeters, By Geography 60
5.3.6.3 North America Table-top Pulse Oximeters, By Geography 60
5.3.6.4 North America Fingertip Pulse Oximeters, By Geography 61
5.3.7 North America Actigraphy Systems Market, By Geography 62
5.4 North America Sleep Apnea Therapeutic Devices Market, By Product/Geography 64
5.4.1 North America PAP Devices Market, By Type/Geography 66
5.4.1.1 North America CPAP Devices, By Geography 68
5.4.1.2 North America APAP Devices, By Geography 69
5.4.1.3 North America Bilevel Devices, By Geography 70
5.4.2 North America Oxygen Devices Market, By Type/Geography 71
5.4.2.1 North America Concentrators Market, By Geography 73
5.4.2.2 North America Home Oxygen Filling Systems Market, By Geography 74
5.4.2.3 North America Liquid Portable Oxygen Market, By Geography 75
5.4.3 North America Oral Appliance Devices Market, By Type/Geography 76
5.4.3.1 North America Mandibular Advancement Device Market, By Geography 77
5.4.3.2 North America Tongue Retaining Device Market, By Geography 78
5.4.4 North America Adaptive Servo-ventilation (ASV) Market, By Geography 79
5.4.5 North America Airway Clearance Systems Market, By Geography 80
6 SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY 82
6.1 INTRODUCTION 83
6.2 U.S. sleep apnea devices MARKET, by segment 84
6.2.1 U.S. Sleep Apnea Diagnostic Devices Market, By Product 85
6.2.2 U.S. Sleep Apnea Therapeutic Devices Market, By Product 87
6.3 Canada sleep apnea devices MARKET, by segment 88
6.3.1 Canada Sleep Apnea Diagnostic Devices Market, By Product 89
6.3.2 Canada Sleep Apnea Therapeutic Devices Market, By Product 91
7 SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE 93
7.1 market shares 93
7.1.1 SLEEP APNEA MARKET SHARES, BY COMPANIES, 2013 93
7.2 KEY GROWTH STRATEGIES 101
7.3 MERGERS & ACQUISITIONS 102
7.4 EXPANSIONS 102
7.5 new product development 103
7.6 partnership 104
7.7 JOINT VENTURES 105
8 SLEEP APNEA DEVICES MARKET, BY COMPANY 106
8.1 BMC Medical Co., Ltd. 106
8.1.1 OVERVIEW 106
8.1.2 KEY FINANCIALS 106
8.1.3 PRODUCT AND SERVICE OFFERINGS 106
8.1.4 RELATED DEVELOPMENTS 107
8.1.5 MMM ANALYSIS 107
8.2 CareFusion Corporation 108
8.2.1 OVERVIEW 108
8.2.2 KEY FINANCIALS 108
8.2.3 PRODUCT OFFERINGS 109
8.2.4 RELATED DEVELOPMENTS 110
8.2.5 MMM ANALYSIS 110
8.3 compumedics limited 111
8.3.1 OVERVIEW 111
8.3.2 KEY FINANCIALS 111
8.3.3 PRODUCT OFFERINGS 112
8.3.4 RELATED DEVELOPMENTS 112
8.3.5 MMM ANALYSIS 113
8.4 fisher aNd paykel healthcare LTD. 114
8.4.1 OVERVIEW 114
8.4.2 KEY FINANCIALS 114
8.4.3 PRODUCT OFFERINGS 116
8.4.4 RELATED DEVELOPMENTS 116
8.4.5 MMM ANALYSIS 116
8.5 natus medical, inc. 118
8.5.1 OVERVIEW 118
8.5.2 KEY FINANCIALS 118
8.5.3 PRODUCT AND SERVICE OFFERINGS 119
8.5.4 RELATED DEVELOPMENTS 120
8.5.5 MMM ANALYSIS 120
8.6 PHILLIPS HEALTHCARE 121
8.6.1 OVERVIEW 121
8.6.2 KEY FINANCIALS 122
8.6.3 PRODUCT AND SERVICE OFFERINGS 123
8.6.4 RELATED DEVELOPMENTS 124
8.6.5 MMM ANALYSIS 125
8.7 RESMED 126
8.7.1 OVERVIEW 126
8.7.2 KEY FINANCIALS 126
8.7.3 PRODUCT AND SERVICE OFFERINGS 127
8.7.4 RELATED DEVELOPMENTS 129
8.7.5 MMM ANALYSIS 130
8.8 Weinmann Medical Devices GmbH & Co. KG 132
8.8.1 OVERVIEW 132
8.8.2 KEY FINANCIALS 132
8.8.3 PRODUCT AND SERVICE OFFERINGS 132
8.8.4 RELATED DEVELOPMENTS 133
8.8.5 MMM ANALYSIS 134
8.9 Ambulatory Monitoring, Inc. 135
8.9.1 OVERVIEW 135
8.9.2 KEY FINANCIALS 135
8.9.3 PRODUCTS 135
8.9.4 RELATED DEVELOPMENTS 135
8.10 Clevemed 136
8.10.1 OVERVIEW 136
8.10.2 KEY FINANCIALS 136
8.10.3 PRODUCT OFFERINGS 136
8.10.4 RELATED DEVELOPMENTS 136
8.11 ADVANCED BRAIN MONITORING, INC. 138
8.11.1 OVERVIEW 138
8.11.2 KEY FINANCIALS 138
8.11.3 PRODUCT OFFERINGS 138
8.11.4 RELATED DEVELOPMENTS 138
8.12 NONIN medical 139
8.12.1 OVERVIEW 139
8.12.2 KEY FINANCIALS 139
8.12.3 PRODUCT OFFERINGS 139
8.12.4 RELATED DEVELOPMENTS 140
8.13 novasom 141
8.13.1 OVERVIEW 141
8.13.2 KEY FINANCIALS 141
8.13.3 PRODUCT OFFERINGS 141
8.13.4 RELATED DEVELOPMENTS 141
8.14 Itamar Medical, Ltd. 142
8.14.1 OVERVIEW 142
8.14.2 KEY FINANCIALS 142
8.14.3 PRODUCT OFFERINGS 142
8.14.4 RELATED DEVELOPMENTS 143
8.14.5 MMM ANALYSIS 143
8.15 cadwell laboratories, inc. 144
8.15.1 OVERVIEW 144
8.15.2 KEY FINANCIALS 144
8.15.3 PRODUCT OFFERINGS 144
8.15.4 RELATED DEVELOPMENTS 145
8.15.5 MMM ANALYSIS 145
8.16 NIHON KOHDEN 146
8.16.1 OVERVIEW 146
8.16.2 KEY FINANCIALS 146
8.16.3 PRODUCT AND SERVICE OFFERINGS 148
8.16.4 RELATED DEVELOPMENTS 148
8.16.5 MMM ANALYSIS 148
9 APPENDIX 150
9.1 Customization Options 150
9.1.1 Product Analysis: 150
9.1.2 Epidemiology Data: 150
9.1.3 Surgeons/Physicians Perception Analysis 150
9.1.4 Regulatory Framework 150
9.1.5 Pricing trends: 150
9.1.6 Competitive intelligence: 150
9.2 Related Reports 151
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 151
9.3.1 RT SNAPSHOTS 152
“LIST OF TABLES
UU
TABLE 1 GLOBAL SLEEP APNEA DEVICES MARKET: PEER MARKET SIZE, 2013 (USD MN) 17
TABLE 2 NORTH AMERICA SLEEP APNEA DEVICES MARKET, 2013 18
TABLE 3 NORTH AMERICA SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2019 (USD MN) 32
TABLE 4 NORTH AMERICA SLEEP APNEA DEVICES MARKET: DRIVERS AND INHIBITORS 32
TABLE 5 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 34
TABLE 6 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 35
TABLE 7 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 38
TABLE 8 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 39
TABLE 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET: TYPE COMPARISON WITH PARENT MARKET, 2012–2019 (USD MN) 40
TABLE 10 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 41
TABLE 11 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 42
TABLE 12 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 44
TABLE 13 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 47
TABLE 14 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 – 2019 (USD MN) 50
TABLE 15 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 50
TABLE 16 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 51
TABLE 17 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 52
TABLE 18 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 53
TABLE 19 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 54
TABLE 20 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 55
TABLE 21 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 56
TABLE 22 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE,
2012 – 2019 (USD MN) 58
TABLE 23 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 58
TABLE 24 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 59
TABLE 25 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 60
TABLE 26 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 61
TABLE 27 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 62
TABLE 28 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 63
TABLE 29 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 65
TABLE 30 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 66
TABLE 31 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN) 67
TABLE 32 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 68
TABLE 33 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 69
TABLE 34 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 70
TABLE 35 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 71
TABLE 36 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN) 72
TABLE 37 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 72
TABLE 38 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 73
TABLE 39 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 74
TABLE 40 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 75
TABLE 41 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 – 2019 (USD MN) 76
TABLE 42 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 77
TABLE 43 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 78
TABLE 44 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 79
TABLE 45 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 80
TABLE 46 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 81
TABLE 47 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 83
TABLE 48 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 83
TABLE 49 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 85
TABLE 50 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN) 86
TABLE 51 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN) 87
TABLE 52 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 89
TABLE 53 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 90
TABLE 54 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 92
TABLE 55 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 94
TABLE 56 NORTH AMERICA SLEEP APNEA DEVICES MARKET: MERGERS & ACQUISITIONS 102
TABLE 57 NORTH AMERICA SLEEP APNEA DEVICES MARKET: EXPANSIONS 102
TABLE 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: NEW PRODUCT DEVELOPMENT 103
TABLE 59 NORTH AMERICA SLEEP APNEA DEVICES MARKET: PARTNERSHIP 104
TABLE 60 NORTH AMERICA SLEEP APNEA DEVICES MARKET: JOINT VENTURES 105
TABLE 61 CAREFUSION CORPORATION: KEY FINANCIALS, 2009 – 2014 (USD MN) 108
TABLE 62 CAREFUSION CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2014 (USD MN) 109
TABLE 63 COMPUMEDICS LIMITED.: KEY FINANCIALS, 2009 – 2013 (USD MN) 111
TABLE 64 COMPUMEDICS LIMITED.: KEY FINANCIALS, BY GEOGRAPHY 2009 – 2013 (USD MN) 112
TABLE 65 FISHER AND PAYKEL HEALTHCARE LTD: KEY FINANCIALS, 2009 – 2013 (USD MN) 114
TABLE 66 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS,
2009 – 2014 (USD MN) 115
TABLE 67 FISHER AND PAYKEL HEALTHCARE LTD: TOTAL REVENUE, BY SEGMENTS,
2009 – 2014 (USD MN) 115
TABLE 68 NATUS MEDICAL, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 118
TABLE 69 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS 2009 – 2013 (USD MN) 119
TABLE 70 ROYAL PHILLIPS ELECTRONICS.: KEY FINANCIALS, 2009 – 2013 (USD MN) 122
TABLE 71 ROYAL PHILLIPS ELECTRONICS.: TOTAL REVENUE, BY SEGMENT 2009 – 2013 (USD MN) 122
TABLE 72 RESMED : KEY FINANCIALS, 2009 – 2013 (USD MN) 126
TABLE 73 RESMED : TOTAL REVENUE, BY SEGMENT 2009 – 2013 (USD MN) 127
TABLE 74 RESMED : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2013 (USD MN) 127
TABLE 75 ITAMAR MEDICAL, LTD.: KEY FINANCIALS, 2009 – 2013 (USD MN) 142
TABLE 76 NIHON KOHDEN.: KEY FINANCIALS, 2009 – 2014 (USD MN) 146
TABLE 77 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT, 2012 – 2014 (USD MN) 147
TABLE 78 NIHON KOHDEN.: TOTAL REVENUE, BY SEGMENT 2012 – 2014 (USD MN) 147
“”LIST OF FIGURES
FIG 1 NORTH AMERICA SLEEP APNEA DEVICES MARKET: SEGMENTATION & COVERAGE 15
FIG 2 SLEEP APNEA DEVICES MARKET: INTEGRATED ECOSYSTEM 16
FIG 3 TOP-DOWN APPROACH 17
FIG 4 DEMAND SIDE APPROACH 18
FIG 5 LEADING CAUSES OF DEATHS (MILLION) IN THE WORLD, 2012 19
FIG 6 COPD PREVALENCE, 2012 19
FIG 7 U.S. PREVALENT CASES FOR LUNG CANCER, 2012 20
FIG 8 LUNG CANCER INCIDENCE, 2012 20
FIG 9 NORTH AMERICA SLEEP APNEA DEVICES MARKET SNAPSHOT 22
FIG 10 SLEEP APNEA MARKET, BY COMORBID CONDITION, 2013 31
FIG 11 NORTH AMERICA SLEEP APNEA DEVICES TYPES, BY GEOGRAPHY, 2013 (USD MN) 35
FIG 12 SLEEP APNEA MARKET, BY SEGMENTS, 2013 37
FIG 13 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 38
FIG 14 NORTH AMERICA SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 39
FIG 15 NORTH AMERICA SLEEP APNEA DEVICES MARKET, TYPE COMPARISON WITH RESPIRATORY DEVICES MARKET, 2012–2019 (USD MN) 40
FIG 16 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 41
FIG 17 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 42
FIG 18 NORTH AMERICA TRADITIONAL DIAGNOSTICS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 43
FIG 19 NUMBER OF SLEEP TESTS (MILLIONS) CONDUCTED IN SLEEP-LABS & AT HOME, U.S.,
2010-2016 45
FIG 20 DECISION MAKING MATRIX AFTER CONDUCTING HOME SLEEP TESTS (HST), U.S., 2013 46
FIG 21 PATIENT RESPONSE MATRIX TOWARDS HOME SLEEP TESTS (HST), U.S., 2012-2013 47
FIG 22 NORTH AMERICA HOME SLEEP TESTING MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 47
FIG 23 U.S. ADULTS THAT HAVE AN ACCESS TO HOME SLEEP TESTING (HST) DEVICES, 2007-2013 48
FIG 24 U.S. PREVALENCE ESTIMATES OF OBSTRUCTIVE SLEEP APNEA (OSA), 2013 48
FIG 25 NORTH AMERICA MASKS MARKET, BY TYPE, 2012 – 2019 (USD MN) 49
FIG 26 NORTH AMERICA MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 50
FIG 27 NORTH AMERICA NASAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 51
FIG 28 NORTH AMERICA FULL FACE MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 52
FIG 29 NORTH AMERICA NASAL PILLOW MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 53
FIG 30 NORTH AMERICA ORAL MASKS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 54
FIG 31 NORTH AMERICA RESPIRATORY POLYGRAPHS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 55
FIG 32 NORTH AMERICA TWO CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 56
FIG 33 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY TYPE,
2012 – 2019 (USD MN) 57
FIG 34 NORTH AMERICA SINGLE CHANNEL SCREENING DEVICES MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 58
FIG 35 NORTH AMERICA HAND-HELD PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 59
FIG 36 NORTH AMERICA WRIST-WORN PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 60
FIG 37 NORTH AMERICA TABLE TOP PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 61
FIG 38 NORTH AMERICA FINGERTIP PULSE OXIMETERS MARKET, BY GEOGRAPHY,
2012–2019 (USD MN) 62
FIG 39 NORTH AMERICA ACTIGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2012–2019 (USD MN) 63
FIG 40 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 64
FIG 41 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 65
FIG 42 NORTH AMERICA PAP DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN) 67
FIG 43 NORTH AMERICA PAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 67
FIG 44 NORTH AMERICA CPAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2018 (USD MN) 68
FIG 45 NORTH AMERICA APAP DEVICES MARKET, BY GEOGRAPHY, 2012 – 2018 (USD MN) 69
FIG 46 NORTH AMERICA BILEVEL DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 70
FIG 47 NORTH AMERICA OXYGEN DEVICES MARKET, BY TYPE, 2012 – 2019 (USD MN) 71
FIG 48 NORTH AMERICA OXYGEN DEVICES MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 72
FIG 49 NORTH AMERICA CONCENTRATORS MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 73
FIG 50 NORTH AMERICA HOME OXYGEN FILLING SYSTEMS MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 74
FIG 51 NORTH AMERICA LIQUID PORTABLE OXYGEN MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 75
FIG 52 NORTH AMERICA ORAL APPLIANCE MARKET, BY TYPE, 2012 – 2019 (USD MN) 76
FIG 53 NORTH AMERICA ORAL APPLIANCE MARKET, BY GEOGRAPHY, 2012 – 2019 (USD MN) 77
FIG 54 NORTH AMERICA MANDIBULAR ADVANCEMENT DEVICE MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 78
FIG 55 NORTH AMERICA TONGUE RETAINING DEVICE MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 79
FIG 56 NORTH AMERICA ADAPTIVE SERVO-VENTILATION MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 80
FIG 57 NORTH AMERICA AIRWAY CLEARANCE SYSTEMS MARKET, BY GEOGRAPHY,
2012 – 2019 (USD MN) 81
FIG 58 NORTH AMERICA SLEEP APNEA DEVICES MARKET: GROWTH ANALYSIS, BY GEOGRAPHY, 2012-2019 (USD MN) 83
FIG 59 U.S. SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%) 84
FIG 60 U.S. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 84
FIG 61 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%) 85
FIG 62 U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN) 86
FIG 63 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT, 2013 & 2019 (%) 87
FIG 64 U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2012 – 2019 (USD MN) 87
FIG 65 CANADA SLEEP APNEA DEVICES MARKET SHARE, BY SEGMENT, 2013 & 2019 (%) 88
FIG 66 CANADA SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2012 – 2019 (USD MN) 88
FIG 67 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY PRODUCT,
2013 & 2019 (%) 89
FIG 68 CANADA SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 90
FIG 69 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY PRODUCT,
2013 & 2019 (%) 91
FIG 70 CANADA SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2012 – 2019 (USD MN) 91
FIG 71 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 94
FIG 72 NORTH AMERICAN HOME SLEEP TEST (HST) DEVICES MARKET, PRODUCT MATRIX, 2013 95
FIG 73 KEY GROWTH STRATEGIES, MARCH 2009–JUNE 2014 101
FIG 75 COMPUMEDICS LIMITED REVENUE MIX, 2013 (%) 111
FIG 76 FISHER AND PAYKEL HEALTHCARE LTD ASA REVENUE MIX, 2013 (%) 114
FIG 79 RESMED REVENUE MIX, 2013 (%) 126
FIG 80 ITAMAR MEDICAL, LTD. REVENUE MIX, 2013 (%) 142
FIG 81 NIHON KOHDEN. REVENUE MIX, 2013 (%) 146
“
“
